Relationship between infectious gastroenteritis and irritable bowel syndrome (Q38548795)

4 September 2017

1 reference

title

Relationship between infectious gastroenteritis and irritable bowel syndrome (English)

1 reference

4 September 2017

1 reference

Motoyori Kanazawa

1

1 reference

PubMed ID

26183503

4 September 2017

Shin Fukudo

series ordinal

2

1 reference

4 September 2017

15 December 2013

1 reference

Clinical journal of gastroenterology

4 September 2017

1 reference

4 September 2017

7

1 reference

4 September 2017

1

1 reference

4 September 2017

14-18

1 reference

https://scigraph.springernature.com/pub.10.1007/s12328-013-0444-4

4 September 2017

0 references

cites work

AGA technical review on irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Postinfectious irritable bowel syndrome--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Development and validation of a risk score for post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

The role of psychological and biological factors in postinfective gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Role for protease activity in visceral pain in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

The serotonin signaling system: from basic understanding to drug development for functional GI disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-013-0444-4

Influence of loperamide on lactose handling and oral-caecal transit time

21 January 2018

1 reference

12 December 2020

Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis

1 reference

12 December 2020

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

1 reference

12 December 2020

The Incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population

1 reference

12 December 2020

The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases

1 reference

12 December 2020

Review of rifaximin as treatment for SIBO and IBS

1 reference

12 December 2020

Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism

1 reference

12 December 2020

10.1007/S12328-013-0444-4

Identifiers

DOI

1 reference

PubMed ID

26183503

Dimensions Publication ID

4 September 2017

0 references

1 reference

PubMed ID

26183503